Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Daxor Corporation
DX5Current price
7.85 EUR
0 EUR (0.00%)
Last closed
8.22 USD
Company
www.daxor.com
ISIN
US2394671034
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
Frankfurt Exchange
Capitalization
40 656 504 USD
Yield for 12 month
-15.36 %
1Y
3Y
5Y
10Y
15Y
DX5
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh. Address: 109 Meco Lane, Oak Ridge, TN, United States, 37830
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
23.38 USDP/E ratio
7.24Dividend Yield
–Current Year
+1 280 515 USD
Last Year
+6 310 294 USD
Current Quarter
+35 878 USD
Last Quarter
+35 878 USD
Current Year
+163 422 USD
Last Year
+6 310 294 USD
Current Quarter
+35 878 USD
Last Quarter
+35 878 USD
Key Figures DX5
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
7.24
Return On Assets TTM
-1.40 %
PEG Ratio
–
Return On Equity TTM
5.35 %
Wall Street Target Price
23.38 USD
Revenue TTM
154 205 USD
Book Value
6.75 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-11.40 %
Dividend Yield
–
Gross Profit TTM
231 641 USD
Earnings per share
1.16 USD
Diluted Eps TTM
1.16 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-57.60 %
Profit Margin
1 094.00 %
Dividend Analytics DX5
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History DX5
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
05.01.2018
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
12.01.2018
Stock Valuation DX5
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
7.24
Forward PE
–
Enterprise Value Revenue
15.79
Price Sales TTM
263.65
Enterprise Value EBITDA
–
Price Book MRQ
1.21
Financials DX5
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DX5
For 52 weeks
7.19 USD
10.04 USD
50 Day MA
9.02 USD
Shares Short Prior Month
6 133
200 Day MA
9.02 USD
Short Ratio
0.60
Shares Short
14 854
Short Percent
0.71 %
BeatStart